NexgenRX Inc. (NXG) - Total Assets
Based on the latest financial reports, NexgenRX Inc. (NXG) holds total assets worth CA$39.20 Million CAD (≈ $28.35 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check NXG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
NexgenRX Inc. - Total Assets Trend (2013–2024)
This chart illustrates how NexgenRX Inc.'s total assets have evolved over time, based on quarterly financial data. Explore NXG long-term investments to assets to see how much of total assets are deployed in long-term investments.
NexgenRX Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
NexgenRX Inc.'s total assets of CA$39.20 Million consist of 80.9% current assets and 19.1% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 5.6% |
| Accounts Receivable | CA$824.27K | 2.7% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$2.33 Million | 7.6% |
| Goodwill | CA$1.24 Million | 4.1% |
Asset Composition Trend (2013–2024)
This chart illustrates how NexgenRX Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NXG company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NexgenRX Inc.'s current assets represent 80.9% of total assets in 2024, a decrease from 84.8% in 2013.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2024, down from 72.6% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 3.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 7.6% of total assets.
NexgenRX Inc. Competitors by Total Assets
Key competitors of NexgenRX Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
India | Rs36.06 Billion |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
USA | $5.84 Billion |
|
DocCheck AG
XETRA:AJ91
|
Germany | €55.68 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
NexgenRX Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 1.09 | 0.97 |
| Quick Ratio | 1.11 | 1.09 | 0.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$3.31 Million | CA$2.19 Million | CA$-623.12K |
NexgenRX Inc. - Advanced Valuation Insights
This section examines the relationship between NexgenRX Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.54 |
| Latest Market Cap to Assets Ratio | 0.74 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | CA$30.46 Million |
| Market Capitalization | $22.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values NexgenRX Inc.'s assets below their book value (0.74x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: NexgenRX Inc.'s assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for NexgenRX Inc. (2013–2024)
The table below shows the annual total assets of NexgenRX Inc. from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$30.46 Million ≈ $22.04 Million |
+0.89% |
| 2023-12-31 | CA$30.20 Million ≈ $21.84 Million |
+17.28% |
| 2022-12-31 | CA$25.75 Million ≈ $18.62 Million |
-12.53% |
| 2021-12-31 | CA$29.44 Million ≈ $21.29 Million |
+16.60% |
| 2020-12-31 | CA$25.24 Million ≈ $18.26 Million |
+19.11% |
| 2019-12-31 | CA$21.19 Million ≈ $15.33 Million |
+17.60% |
| 2018-12-31 | CA$18.02 Million ≈ $13.04 Million |
+86.41% |
| 2017-12-31 | CA$9.67 Million ≈ $6.99 Million |
+18.12% |
| 2016-12-31 | CA$8.19 Million ≈ $5.92 Million |
+24.76% |
| 2015-12-31 | CA$6.56 Million ≈ $4.75 Million |
+814.78% |
| 2014-12-31 | CA$717.20K ≈ $518.81K |
-46.33% |
| 2013-12-31 | CA$1.34 Million ≈ $966.72K |
-- |
About NexgenRX Inc.
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquarte… Read more